Additional information
by Sebastian Porsdam Mann (Author), Helle Porsdam (Author), Maximilian M. Schmid (Author)
Scientists are supposed to have freedom to choose and conduct their experiments and exchange their ideas. Known as scientific freedom, this idea has been implicated in both wonderful and terrible scientific discoveries. Although it is not new, it has great relevance to contemporary society. In a time of genetic editing, global warming, and a worldwide pandemic, the question of how freely science is and should be conducted is one that has significant practical consequences.
Drawing on rigorous interdisciplinary methods, this book defines the concept of scientific freedom, tells its story, and asks on what basis scientific freedom is best justified. Based on international human rights law and philosophy, the authors develop a model of scientific freedom as a constitutive element of the human right to enjoy the benefits of the progress of science and its applications. To illustrate its usefulness, they then test and apply this model to a real-life and real-time case study, as well as to two highly important international human rights instruments.Author Biography
Sebastian Porsdam Mann is research fellow at the Faculty of Law, Oxford, and a researcher at UEHIRO Centre of Ethics, University of Oxford. He is Chief Academic Officer at A&BC Consulting and Postdoc fellow at Harvard Medical School Center for Bioethics.
Helle Porsdam is professor of Law and Humanities and UNESCO Chair in Cultural Rights at the University of Copenhagen. She has headed research projects and published widely on the interface of cultural rights, copyright, creativity and cultural heritage institutions. In 2021 she was awarded a Leverhulme Visiting Professor at the Centre for Research in the Arts, Humanities and Social Sciences University of Cambridge.
Maximilian M. Schmid studied international business at Munich Business School and carried out graduate work in management at IE Business School in Madrid. After a year of international experience working for Cosana in Tokyo, MMS and SPM founded and is the CEO of A&BC Consulting. Since 2019 MMS has been the managing director of Cosana Europe.
Péter Vilmos Treit is research fellow at the Max Plank Institute of Biochemistry. He studied biomedical sciences at Queen Mary University in London, before embarking on graduate work in biochemistry at Ludwig-Maximillian-University in Munich. He has worked as a research assistant and laboratory scientist in the Department of Proteomics and Signal Transduction at the Max Planck Institute of Biochemistry.
